Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-14-009081)

Filing Details

Accession Number:: 0001437749-14-009081
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-14 17:10:54
Reporting Period:: 2014-05-09

Filing Date:: 2014-05-14
Accepted Time:: 2014-05-14 17:10:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593299	Ltd Holdings Pharma Pioneer China	190 Elgin Ave Georgetown Grand Cayman, Cayman Islands KY1-9005		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-09	318,828	$0.99	426,984	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,005,656	Indirect	By Pioneer Pharma (Singapore) Pte Ltd

Footnotes

The shares are held by Pioneer Pharma (Singapore) Pte Ltd, which is a wholly owned subsidiary of Pioneer Pharma (Hong Kong) Company Limited, which is a wholly owned subsidiary of the Reporting Person.